Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.51 |
| ▸ | TRPM8 | Q7Z2W7 | 5/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6870235 | 0.95 | EPHX1 (0.49) | EPHX1TRPM8OPRM1TRPA1CA12 | |
| SCHEMBL6871882 | 0.94 | EPHX1 (0.54) | EPHX1TRPM8OPRM1TRPA1CA12 | |
| SCHEMBL6869088 | 0.89 | EPHX1 (0.51) | EPHX1TRPM8OPRM1TRPA1 | |
| SCHEMBL6872036 | 0.88 | EPHX1 (0.60) | EPHX1TRPM8OPRM1TRPA1 | |
| SCHEMBL6871336 | 0.86 | EPHX1 (0.51) | EPHX1TRPM8OPRM1TRPA1 | |
| SCHEMBL6872884 | 0.85 | EPHX1 (0.57) | EPHX1TRPM8OPRM1TRPA1 | |
| Hexane SCHEMBL28846476 | 0.84 | EPHX1 (0.62) | EPHX1TRPM8OPRM1TRPA1 | |
| SCHEMBL2160803 | 0.82 | EPHX1 (0.53) | EPHX1TRPM8OPRM1TRPA1 | |
| SCHEMBL11412976 | 0.80 | EPHX1 (0.57) | EPHX1TRPM8TRPA1 | |
| SCHEMBL1863061 | 0.77 | EPHX1 (0.57) | EPHX1TRPM8OPRM1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1311158-B1 | COMPOSITION HAVING INSECT REPELLENT CHARACTERISTICS | GIVAUDAN SA (CH) | 2004-08-11 | — | — | EP | disclosed |
| US-20040028714-A1 | Composition having insect repellent characteristics | GIVAUDAN SA (CH) | 2004-02-12 | — | — | US | disclosed |
| EP-1311158-A1 | COMPOSITION HAVING INSECT REPELLENT CHARACTERISTICS | Givaudan SA (CH) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002015692-A1 | COMPOSITION HAVING INSECT REPELLENT CHARACTERISTICS | GIVAUDAN SA (CH) | 2002-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040028714-A1 | Composition having insect repellent characteristics | SUV39H1, PNMT, SUV39H2 | EPHX1 690/4885TRPM8 36/4885OPRM1 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.